Clinical Trials

To learn more about the EMBOLD study for children diagnosed with SCN2A and SCN8A DEEs, please visit www.emboldstudy.org

To learn more about the EMBRAVE study for children diagnosed with early-onset SCN2A DEEs, please visit www.embravestudy.org
Scientific Publications
Ulixacaltamide |
---|
2022 AAN Annual Meeting
|
2022 MDS Congress
|
2023 IAPRD Meeting |
2023 MDS Congress |
PRAX-944 Translational Findings inMovement Disorders
|
ET Claims Analysis inAdvances in Therapy |
TTCC Mechanistic Review inAnnals of Clinical and Translational Neurology |
PRAX-562 |
---|
2021 AES Annual Meeting
|
2022 Epilepsy Foundation Pipeline Conference
|
2022 Familes of SCN2A and SCN8A Advocacy Talk |
2022 AES Annual Meeting and Behind the Seizure Scientific Exhibit |
2023 IEC Annual Meeting
|
PRAX-562 Pharmacology inEpilepsia
|
PRAX-222 |
---|
2022 AES Annual Meeting and Behind the Seizure Scientific Exhibit |
2022 Drug Discovery for Ion Channels XXII Meeting |
2023 Oligonucleotides for CNS Meeting |
Other |
---|
2021 AES Annual Meeting
|
PRX-2904 Chemistry inACS Medicinal Chemistry Letters
|